NCT02710188View on ClinicalTrials.gov

Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

August 31, 2016

Conditions

Alzheimer's Disease

Interventions

DRUG

HTL0009936 modified release

HTL0009936 modified release

DRUG

HTL0009936 immediate release

HTL0009936 immediate release

Trial Locations (1)

NG11 6JS

Quotient Clinical, Ruddington

Sponsors

Collaborators (1)

Quotient Clinical

All Listed Sponsors

collaborator

Quotient Clinical

OTHER

lead

Nxera Pharma UK Limited

INDUSTRY